Inloggad som:

ZUMA-4

Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.
ZUMA-4
A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-X19 in Pediatric and Adolescent Subjects with Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-X19 in Pediatric and Adolescent Subjects with Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
PLACEHOLDER
Mer information om studien för vårdgivare
Behandling
Fas 1-2
Palliativ
Företag
https://classic.clinicaltrials.gov/ct2/show/NCT02625480

Studien ändrades senast av: studysonia (2023-06-27)

Tillbaka till listan